Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    The Insulet logo displays a stylized purple and white design featuring a unique island shape with a prominent white wave

    Insulet

    Insulet Corporation is a global leader in innovative, wearable insulin delivery systems, dedicated to simplifying diabetes management through its Omnipod technology and headquartered in Acton, Massachusetts.

    Company Overview

    Insulet Corporation is a pioneering medical device company specializing in the development and manufacturing of tubeless, wearable insulin management systems for people with diabetes. The company’s flagship product, Omnipod, offers a unique alternative to traditional insulin delivery, enhancing patient freedom and quality of life. With a global presence and a strong focus on innovation, Insulet serves customers in over 25 countries.

    Key Metrics

    350

    Import Shipments

    4

    Distribution Centers

    2.1B

    Annual Revenue

    2000

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Insulet is likely focused on expanding its Omnipod product line, enhancing digital health integration, and increasing global market penetration in response to rising diabetes prevalence and demand for wearable medical technology.

    Strategic Expansion

    Launch of next-generation Omnipod devices with improved connectivity and automation

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Insulet Corporation designs, manufactures, and markets the Omnipod Insulin Management System, a revolutionary tubeless and wireless insulin pump that provides continuous insulin delivery for up to three days. The company’s mission is to improve the lives of people with diabetes and reduce the burden of daily management through advanced, user-friendly technology. Insulet operates highly automated manufacturing facilities and maintains a significant global workforce to support its expanding customer base. The company also explores the application of its pod-based technology for other subcutaneous drug delivery needs.

    Headquarters

    Acton, Massachusetts, USA

    Founded

    2000

    Stock Symbol

    PODD